YCX26· AIFinalDose
Programmable DNA drug destroying all cancers, unlocking 80% of targets
Founders
- Jeff LiuFounder/CEO
- Li-Yao HuangFounder
- Steven LinFounder
Same space
Competitors
Closest in what they build, same category.
Adjacent
Overlapping tags, a different niche.
Kopra BioS24Genetically engineered viruses that teach your immune system to kill…Shared: gene therapy, therapeuticsActive
Andson BiotechW22Empowering Mass Spec for Biotech and BeyondShared: gene therapy, therapeuticsActive
ParcelBioW24Elevated mRNA for transformative medicines.Shared: gene therapy, therapeuticsActive
Nuntius TherapeuticsW21Cell-specific genetic medicinesShared: gene therapyActive
AlixiaW22Targeting the Tumor Ecosystem to address cancer drug resistance.Shared: therapeuticsActive
Also from X26 in AI
Batchmates in Spring 2026.
AbInitio BioX26The Intelligence layer for Drug ManufacturingActive
Advanced Metal ResearchX26Machine intelligence for American WeldingActive
AgentPhoneX26Phone Numbers for AI AgentsActive
AkkariX26Autonomous Customer OperationsActive
AllowanceX26The spend control layer for AI agentsActive
AmborasX26AI Native ShopifyActive
About FinalDose
FinalDose is building the first programmable drug - a single smart drug molecule that you can insert any diseased genetic code and it can search and destroy cells upon DNA recognition. Unlocking 80% of undruggable targets today. Starting with all cancers.
Oxford, England, United Kingdom
FinalDose: questions
Which YC batch was FinalDose in?
FinalDose was in Y Combinator's Spring 2026 batch (X26).
Is FinalDose still active?
Y Combinator lists FinalDose as active.
Who founded FinalDose?
FinalDose's founders, as listed on its YC page: Jeff Liu (Founder/CEO), Li-Yao Huang (Founder), Steven Lin (Founder).
Where is FinalDose based?
FinalDose lists Oxford, England, United Kingdom as its location on YC's directory.
Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.